Nasal uptake of inhaled acrolein in rats.
An improved understanding of the relationship between inspired concentration of the potent nasal toxicant acrolein and delivered dose is needed to support quantitative risk assessments. The uptake efficiency (UE) of 0.6, 1.8, or 3.6 ppm acrolein was measured in the isolated upper respiratory tract (URT) of anesthetized naive rats under constant-velocity unidirectional inspiratory flow rates of 100 or 300 ml/min for up to 80 min. An additional group of animals was exposed to 0.6 or 1.8 ppm acrolein, 6 h/day, 5 days/wk, for 14 days prior to performing nasal uptake studies (with 1.8 or 3.6 ppm acrolein) at a 100 ml/min airflow rate. Olfactory and respiratory glutathione (GSH) concentrations were also evaluated in naive and acrolein-preexposed rats. Acrolein UE in naive animals was dependent on the concentration of inspired acrolein, airflow rate, and duration of exposure, with increased UE occurring with lower acrolein exposure concentrations. A statistically significant decline in UE occurred during the exposures. Exposure to acrolein vapor resulted in reduced respiratory epithelial GSH concentrations. In acrolein-preexposed animals, URT acrolein UE was also dependent on the acrolein concentration used prior to the uptake exposure, with preexposed rats having higher UE than their naive counterparts. Despite having increased acrolein UE, GSH concentrations in the respiratory epithelium of acrolein preexposed rats were higher at the end of the 80 min acrolein uptake experiment than their in naive rat counterparts, suggesting that an adaptive response in GSH metabolism occurred following acrolein preexposure.
Struve
Melanie F
MF
CIIT at The Hamner Institutes for Health Sciences, Research Triangle Park, North Carolina, USA.
Wong
Victoria A
VA
Marshall
Marianne W
MW
Kimbell
Julia S
JS
Schroeter
Jeffry D
JD
Dorman
David C
DC
D000171:Acrolein / Q000493:pharmacokinetics*; D000393:Air Pollutants / Q000493:pharmacokinetics*; D000818:Animals; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005978:Glutathione / Q000378:metabolism; D019570:Inhalation Exposure; D008168:Lung / Q000378:metabolism; D008297:Male; D009296:Nasal Cavity / Q000378:metabolism*; D051381:Rats; D011916:Rats, Inbred F344; D020545:Respiratory Mucosa / Q000378:metabolism
D000393:Air Pollutants; D000171:Acrolein; D005978:Glutathione